Health Care & Life Sciences » Pharmaceuticals | Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
160,044
272,865
281,086
313,081
264,895
290,659
Cost of Goods Sold (COGS) incl. D&A
57,172
132,604
131,135
154,430
122,246
155,893
Gross Income
102,872
140,262
149,951
158,651
142,648
134,766
SG&A Expense
32,871
69,547
72,256
71,062
101,565
89,223
EBIT
69,560
68,831
-
84,885
41,083
45,543
Unusual Expense
27,554
4,320
6,364
476
9,505
-
Non Operating Income/Expense
2,204
2,742
1,948
4,946
8,388
1,889
Interest Expense
442
5,789
4,694
3,560
5,176
5,553
Pretax Income
45,831
64,029
65,706
90,479
34,790
38,102
Income Tax
7,022
9,147
9,138
12,116
8,452
6,009
Equity in Affiliates
-
126
15
99
254
15
Consolidated Net Income
38,809
54,757
56,583
78,462
26,084
32,079
Net Income
31,434
45,394
45,457
69,644
21,616
26,654
Net Income After Extraordinaries
31,453
45,394
45,457
69,644
21,616
26,654
Net Income Available to Common
31,415
45,394
45,457
69,644
21,616
26,654
EPS (Basic)
15.20
18.90
18.90
29.00
9.00
11.11
Basic Shares Outstanding
2,071
2,405
2,406
2,403
-
-
EPS (Diluted)
15.17
18.87
18.88
28.98
-
-
Diluted Shares Outstanding
2,071
2,406
2,407
2,404
-
-
EBITDA
73,652
80,778
85,516
97,532
56,081
63,076
Other Operating Expense
442
1,884
2,555
2,704
-
-
Non-Operating Interest Income
2,063
2,564
3,572
3,712
-
-
Minority Interest Expense
7,375
9,363
11,126
8,819
4,468
5,424

About Sun Pharmaceutical Industries

View Profile
Address
CTS No. 201 B/1, Sun House
Mumbai Maharashtra 400063
India
Employees -
Website http://www.sunpharma.com
Updated 07/08/2019
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It operates through the following geographical segments: India, United States of America, Emerging Markets, and Rest of the World. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.